Clinical Trial Update: RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms [Phase 2]

View source ↗

Summary

RECOVER-VITAL describes a Phase 2 platform protocol to evaluate the impact of antiviral therapies on long COVID symptoms, with results posted in December 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Kanecia Obie Zimmerman | Conditions: Long COVID, Long Covid19 | Phase 2 | Status: COMPLETED | Results posted: 2025-12-02